UNSPSC 51192201: Amiloride/hydrochlorothiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV704. This VA Drug Class (CV704) classifies this compound as belonging to the group POTASSIUM SPARING/COMBINATIONS DIURETICS.

UNSPSC 51192201 Amiloride/hydrochlorothiazide is a Commodity code with minimal alignment between its nominal scope—a branded diuretic combination pharmaceutical—and actual state and local procurement activity tagged under it. The recent opportunities block contains one solicitation for sodium bisulfite, a water-treatment chemical unrelated to the drug, and one multistate RFP for generic pharmaceuticals and OTC products that does not specify amiloride/hydrochlorothiazide in its scope. State and local governments do not appear to be actively procuring this specific pharmaceutical as a line-item commodity under this code.

The one potentially relevant recent opportunity is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802, posted January 20, 2026, with a response deadline of March 26, 2026. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, sought generic multi-source pharmaceuticals and OTC products on behalf of participating state and local facilities across multiple states including Oregon. The RFP required vendors to supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and to certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. Evaluation weighted price competitiveness at 75 percent, with fixed pricing, administrative fee compliance, EDI capability, and pricing format flexibility making up the remainder. Contract term was two years for new responders with optional extensions, though no specific award values or product-level guarantees were disclosed. The scope does not explicitly name amiloride/hydrochlorothiazide among identified pharmaceutical products, making pursuit under this code code unlikely without direct confirmation from MMCAP that the product is within the awarded vendor's supply mandate.